BioNTech to build mRNA manufacturing site in Singapore

Reuters2021-05-10

BERLIN, May 10 (Reuters) - BioNTech said on Monday it plans to set up a regional headquarters and build a new manufacturing site for its vaccines based on messanger RNA technology (mRNA) in Singapore, in the latest move to expand its production network.

The Mainz-based company said it plans to open the Singapore office in 2021 and expects the manufacturing site to be operational by 2023, creating up to 80 jobs in Singapore.

"Having multiple nodes in our production network is an important strategic step in building out our global footprint and capabilities," said Ugur Sahin, CEO and Co-founder of BioNTech.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • BlessedCyrus
    2021-05-10
    BlessedCyrus
    Nice!!
  • Elgk
    2021-05-10
    Elgk
    Great. Pls like comment tqtq 
  • JQ62
    2021-05-10
    JQ62
    Love it
  • DingDang
    2021-05-10
    DingDang
    I love sg!! Please like and comment!
  • WZiYa
    2021-05-10
    WZiYa
    Great to know. 
  • Chimmy
    2021-05-10
    Chimmy
    For a moment I thought they start to manufacture the vaccines now. Then I read its 2023.But its nice SG has convinced another MNC to set us biz here
发表看法
9